CYP19A1 and ductal breast carcinoma in situ: Recommended treatment options include mastectomy with sentinel lymph node biopsy, breast-conserving surgery alone or followed by radiotherapy, with the potential addition of hormonal therapy with Tamoxifen or Aromatase Inhibitors in postmenopausal patients for DCIS cases that express hormone receptors [2,9].